Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Vera L. Alves, João L. Gonçalves, Joselin Aguiar, Helena M. Teixeira & José S. Câmara. (2020) The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review. Critical Reviews in Toxicology 50:5, pages 359-382.
Read now
Read now
A. J. Potts, C. Cano, S. H. L. Thomas & S. L. Hill. (2020) Synthetic cannabinoid receptor agonists: classification and nomenclature. Clinical Toxicology 58:2, pages 82-98.
Read now
Read now
Jose Orsini, Nanda Din, Ershad Elahi, Anthony Gomez, Salil Rajayer, Ryan Malik & Elie Jean. (2017) Clinical and epidemiological characteristics of patients with acute drug intoxication admitted to ICU. Journal of Community Hospital Internal Medicine Perspectives 7:4, pages 202-207.
Read now
Read now
Genevieve Lafaye, Laurent Karila, Lisa Blecha & Amine Benyamina. (2017) Cannabis, cannabinoids, and health. Dialogues in Clinical Neuroscience 19:3, pages 309-316.
Read now
Read now
Juliana Tournebize, Valérie Gibaja & Jean-Pierre Kahn. (2017) Acute effects of synthetic cannabinoids: Update 2015. Substance Abuse 38:3, pages 344-366.
Read now
Read now
Articles from other publishers (65)
Gabriela Raluca Grigorasi, Mihaela Corlade-Andrei, Irina Ciumanghel, Ivona Sova, Teofil Blaga, Claudiu Carp & Diana Cimpoesu. (2023) Monitoring Perfusion Index in Patients Presenting to the Emergency Department Due to Drug Use. Journal of Personalized Medicine 13:2, pages 372.
Crossref
Crossref
Giovanni Graziano, Pietro Delre, Francesca Carofiglio, Josè Brea, Alessia Ligresti, Magdalena Kostrzewa, Chiara Riganti, Claudia Gioè-Gallo, Maria Majellaro, Orazio Nicolotti, Nicola Antonio Colabufo, Carmen Abate, Maria Isabel Loza, Eddy Sotelo, Giuseppe Felice Mangiatordi, Marialessandra Contino, Angela Stefanachi & Francesco Leonetti. (2023) N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R). European Journal of Medicinal Chemistry 248, pages 115109.
Crossref
Crossref
Rui Filipe Malheiro, Helena Carmo, Félix Carvalho & João Pedro Silva. (2023) Cannabinoid-mediated targeting of mitochondria on the modulation of mitochondrial function and dynamics. Pharmacological Research 187, pages 106603.
Crossref
Crossref
Ziteng Wang, Eric Yu Quan Leow, Hooi Yan Moy & Eric Chun Yong Chan. 2023.
Shima Afshar, Mohammad Abbasinazari, Gholamreza Amin, Amir Farrokhian, Mohammad Sistanizad, Fariba Afshar & Shayesteh Khalili. (2022) Endocannabinoids and related compounds as modulators of angiogenesis: Concepts and clinical significance. Cell Biochemistry and Function 40:8, pages 826-837.
Crossref
Crossref
Sara Malaca, Francesco P. Busardò, Giulio Nittari, Ascanio Sirignano & Giovanna Ricci. (2022) Fourth Generation of Synthetic Cannabinoid Receptor Agonists: A Review on
the Latest Insights. Current Pharmaceutical Design 28:32, pages 2603-2617.
Crossref
Crossref
Gabriel L Streun, Andrea E Steuer, Sandra N Poetzsch, Lars C Ebert, Akos Dobay & Thomas Kraemer. (2022) Towards a New Qualitative Screening Assay for Synthetic Cannabinoids Using Metabolomics and Machine Learning. Clinical Chemistry 68:6, pages 848-855.
Crossref
Crossref
Avery E. Michienzi & Heather A. Borek. (2022) Emerging Agents of Substance Use/Misuse. Emergency Medicine Clinics of North America 40:2, pages 265-281.
Crossref
Crossref
E.N.T. Vikram, R. Ilavarasan & R. Kamaraj. (2022) Anti-cancer activities of Schedule E1 drugs used in ayurvedic formulations. Journal of Ayurveda and Integrative Medicine 13:2, pages 100545.
Crossref
Crossref
A.-L. Pélissier-Alicot. 2022. Cannabis and the Developing Brain. Cannabis and the Developing Brain
243
258
.
Frank T. Peters & Markus R. Meyer. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
225
244
.
João Pedro Silva, Helena Carmo & Félix Carvalho. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
1321
1342
.
João Pedro Silva, Helena Carmo & Félix Carvalho. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
1
22
.
Nao Wu, Saïda Danoun, Stéphane Balayssac, Myriam Malet-Martino, Catherine Lamoureux & Véronique Gilard. (2021) Synthetic cannabinoids in e-liquids: A proton and fluorine NMR analysis from a conventional spectrometer to a compact one. Forensic Science International 324, pages 110813.
Crossref
Crossref
Pierpaolo Tomai, Alessandra Gentili, Roberta Curini, Rossella Gottardo, Franco Tagliaro & Salvatore Fanali. (2021) Dispersive liquid-liquid microextraction, an effective tool for the determination of synthetic cannabinoids in oral fluid by liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical Analysis 11:3, pages 292-298.
Crossref
Crossref
Mariantonia Braile, Simone Marcella, Gianni Marone, Maria Rosaria Galdiero, Gilda Varricchi & Stefania Loffredo. (2021) The Interplay between the Immune and the Endocannabinoid Systems in Cancer. Cells 10:6, pages 1282.
Crossref
Crossref
José F. Oliveira da Cruz, Christina Ioannidou, Antonio C. Pagano Zottola, Carolina Muguruza, Paula Gomez‐Sotres, Monica Fernandez, Luis F. Callado, Giovanni Marsicano & Arnau Busquets‐Garcia. (2020) Sex‐dependent pharmacological profiles of the synthetic cannabinoid MMB‐Fubinaca. Addiction Biology 26:3.
Crossref
Crossref
Danièle Debruyne, Emilie Monzon, Justine Perino, Françoise Haramburu, Amélie Daveluy, Aurélie Lazès-Charmetant & Isabelle Giraudon. (2021) Usages de substances de synthèse en France et en Europe. Therapies 76:3, pages 221-228.
Crossref
Crossref
Julie Chas, Rebecca Bauer, Islam Amine Larabi, Gilles Peytavin, Perrine Roux, Eric Cua, Laurent Cotte, Armelle Pasquet, Catherine Capitant, Laurence Meyer, Francois Raffi, Bruno Spire, Gilles Pialoux, Jean-Michel Molina & Jean-Claude Alvarez. (2021) Evaluation of Drug Abuse by Hair Analysis and Self-Reported Use Among MSM Under PrEP: Results From a French Substudy of the ANRS-IPERGAY Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes 86:5, pages 552-561.
Crossref
Crossref
Ken-ichi Tomiyama & Masahiko Funada. (2020) Synthetic cannabinoid CP-55,940 induces apoptosis in a human skeletal muscle model via regulation of CB1 receptors and l-type Ca2+ channels. Archives of Toxicology 95:2, pages 617-630.
Crossref
Crossref
Yigit Sezer, Ayse Tarbin Jannuzzi, Marilyn A Huestis & Buket Alpertunga. (2020)
In vitro
assessment of the cytotoxic, genotoxic and oxidative stress effects of the synthetic cannabinoid JWH-018 in human SH-SY5Y neuronal cells
. Toxicology Research 9:6, pages 734-740.
Crossref
Crossref
Laith AL-Eitan, Ahmed Alhusban & Saif Alahmad. (2020) Effects of the synthetic cannabinoid XLR-11 on the viability and migration rates of human brain microvascular endothelial cells in a clinically-relevant model. Pharmacological Reports 72:6, pages 1717-1724.
Crossref
Crossref
Yan Shi, Liying Zhou, Le Li, Mengxi Liu, Huosheng Qiang, Min Shen, Baohua Shen, Hang Chen, Olaf H. Drummer, Wanhui Liu, Hejian Wu & Ping Xiang. (2020) Detection of a New Tert-Leucinate Synthetic Cannabinoid 5F-MDMB-PICA and Its Metabolites in Human Hair: Application to Authentic Cases. Frontiers in Chemistry 8.
Crossref
Crossref
Koby Cohen, Shiri Rosenzweig, Paola Rosca, Albert Pinhasov, Abraham Weizman & Aviv Weinstein. (2020) Personality Traits and Psychotic Proneness Among Chronic Synthetic Cannabinoid Users. Frontiers in Psychiatry 11.
Crossref
Crossref
Brandon C. Presley, Barry K. Logan & Susan A. Jansen‐Varnum. (2020) Phase I metabolism of synthetic cannabinoid receptor agonist PX‐1 (5F‐APP‐PICA) via incubation with human liver microsomes and UHPLC–HRMS. Biomedical Chromatography 34:3.
Crossref
Crossref
Rui Shen Ong, Diana C. Kappatos, Sarah G.G. Russell, Helen A. Poulsen, Samuel D. Banister, Roy R. Gerona, Michelle Glass, Cameron S. Johnson & Mary‐Jane McCarthy. (2019) Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography–tandem mass spectrometry – A New Zealand perspective of use in 2018. Drug Testing and Analysis 12:2, pages 195-214.
Crossref
Crossref
James W. Firman, Samuel J. Belfield, George Chen, Megan Jackson, Fai Hou Lam, Callum Richmond, James Smith, Fabian P. Steinmetz & Mark T. D. Cronin. (2019) Chemoinformatic Consideration of Novel Psychoactive Substances: Compilation and Preliminary Analysis of a Categorised Dataset. Molecular Informatics 38:8-9, pages 1800142.
Crossref
Crossref
Erin C Strickland, Oneka T Cummings, Allyson L Mellinger & Gregory L McIntire. (2019) Development and Validation of a Novel All-Inclusive LC–MS-MS Designer Drug Method. Journal of Analytical Toxicology 43:3, pages 161-169.
Crossref
Crossref
Angela Jury, Jennifer Lai, Charito Tuason, Ashley Koning, Mark Smith, Lois Boyd, Caro Swanson, David Fergusson & Angela Gruar. (2019) People who experience seclusion in adult mental health inpatient services: An examination of health of the nation outcome scales scores. International Journal of Mental Health Nursing 28:1, pages 199-208.
Crossref
Crossref
Laurent Karila & Amine Benyamina. 2019. Cannabis Use Disorders. Cannabis Use Disorders
169
176
.
Andreas K. Breitbarth, Jody Morgan & Alison L. Jones. (2018) E-cigarettes—An unintended illicit drug delivery system. Drug and Alcohol Dependence 192, pages 98-111.
Crossref
Crossref
Tiago Rosado, Joana Gonçalves, Ângelo Luís, Sara Malaca, Sofia Soares, Duarte Nuno Vieira, Mário Barroso & Eugenia Gallardo. (2018) Synthetic cannabinoids in biological specimens: a review of current analytical methods and sample preparation techniques. Bioanalysis 10:19, pages 1609-1623.
Crossref
Crossref
Samuel K. Cordeiro, Ryan C. Daro, Hyunuk Seung, Wendy Klein-Schwartz & Hong K. Kim. (2018) Evolution of clinical characteristics and outcomes of synthetic cannabinoid receptor agonist exposure in the United States: analysis of National Poison Data System data from 2010 to 2015. Addiction 113:10, pages 1850-1861.
Crossref
Crossref
Thomas Heinbockel & Antonei Csoka. (2018) Epigenetic Effects of Drugs of Abuse. International Journal of Environmental Research and Public Health 15:10, pages 2098.
Crossref
Crossref
Vincenzo Di Marzo. (2018) New approaches and challenges to targeting the endocannabinoid system. Nature Reviews Drug Discovery 17:9, pages 623-639.
Crossref
Crossref
Vincenzo Abbate, Michael Schwenk, Brandon C. Presley & Nahoko Uchiyama. (2018) The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report). Pure and Applied Chemistry 90:8, pages 1255-1282.
Crossref
Crossref
Masaki Domoto, Hitoki Sasase, Shintaro Wada, Shiho Ito, Satoshi Deyama, Eiichi Hinoi, Shuji Kaneko & Katsuyuki Kaneda. (2018) The synthetic cannabinoid 5F-AMB changes the balance between excitation and inhibition of layer V pyramidal neurons in the mouse medial prefrontal cortex. Psychopharmacology 235:8, pages 2367-2376.
Crossref
Crossref
Anthea B. Mahesan Paul, Lary Simms, Saeideh Amini & Abraham Ebenezer Paul. (2018) Teens and Spice: A Review of Adolescent Fatalities Associated with Synthetic Cannabinoid Use. Journal of Forensic Sciences 63:4, pages 1321-1324.
Crossref
Crossref
Annelies Cannaert, Jolien Storme, Cornelius Hess, Volker Auwärter, Sarah M R Wille & Christophe P Stove. (2018) Activity-Based Detection of Cannabinoids in Serum and Plasma Samples. Clinical Chemistry 64:6, pages 918-926.
Crossref
Crossref
Oscar J. León, Leonar G. Aguiar, Leonardo A. Quevedo & Ana B. Jara. (2018) Efectos cardiovasculares debido al consumo de cannabinoides. Revista Colombiana de Cardiología 25:3, pages 230-235.
Crossref
Crossref
Patil Armenian, Michael Darracq, Jirair Gevorkyan, Shane Clark, Bryan Kaye & Nicklaus P. Brandehoff. (2018) Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A case series and review of the literature. Neuropharmacology 134, pages 82-91.
Crossref
Crossref
Payal Sud, Miles Gordon, Laura Tortora, Matthew Stripp, Damon Borg & Adam Berman. (2018) Retrospective Chart Review of Synthetic Cannabinoid Intoxication with Toxicologic Analysis. Western Journal of Emergency Medicine 19:3, pages 567-572.
Crossref
Crossref
Maiko Kusano, Kei Zaitsu, Kentaro Taki, Kazuaki Hisatsune, Jun'ichi Nakajima, Takako Moriyasu, Tomomi Asano, Yumi Hayashi, Hitoshi Tsuchihashi & Akira Ishii. (2018) Fatal intoxication by 5F-ADB and diphenidine: Detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q-TOFMS. Drug Testing and Analysis 10:2, pages 284-293.
Crossref
Crossref
B.L.F. Kaplan. 2018. Comprehensive Toxicology. Comprehensive Toxicology
791
825
.
Eric Rowley, David Benson, Aaron Tiffee, Adam Hockensmith, Henry Zeng, Glenn N. Jones & Mandi W. Musso. (2017) Clinical and financial implications of emergency department visits for synthetic marijuana. The American Journal of Emergency Medicine 35:10, pages 1506-1509.
Crossref
Crossref
Zurina Hassan, Oliver G. Bosch, Darshan Singh, Suresh Narayanan, B. Vicknasingam Kasinather, Erich Seifritz, Johannes Kornhuber, Boris B. Quednow & Christian P. Müller. (2017) Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs. Frontiers in Psychiatry 8.
Crossref
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
Jacopo Lucchetti, Claudio M. Marzo, Angelo Di Clemente, Luigi Cervo & Marco Gobbi. (2017)
A validated, sensitive HPLC-MS/MS method for quantification of
cis-para
-methyl-4-methylaminorex (
cis
-4,4'-DMAR) in rat and human plasma: application to pharmacokinetic studies in rats
. Drug Testing and Analysis 9:6, pages 870-879.
Crossref
Crossref
Natalie Thurtle, Rachelle Abouchedid, John R. H. Archer, James Ho, Takahiro Yamamoto, Paul I. Dargan & David M. Wood. (2016) Prevalence of Use of Electronic Nicotine Delivery Systems (ENDS) to Vape Recreational Drugs by Club Patrons in South London. Journal of Medical Toxicology 13:1, pages 61-65.
Crossref
Crossref
Nathalie Allibe, Camille Richeval, Théo Willeman, Luc Humbert, Delphine Allorge, Maxime Maignan, Hélène Eysseric-Guerin, Françoise Stanke-Labesque & Jean-Michel Gaulier. (2017) Case reports: Four concomitant non-fatal intoxications with AB-FUBINACA and MDMA. Toxicologie Analytique et Clinique 29:1, pages 101-110.
Crossref
Crossref
Florent Brousse, Julie Deseille, Mathilde Ferdonnet, Alain Gond, Paul Lafargue, Bernard Marc & Jacques Raveneau. (2017) Drogues, les nouveaux produits de synthèse : nouveaux défis pour la santé et la sécurité publiques. Revue Francophone des Laboratoires 2017:489, pages 98-102.
Crossref
Crossref
R Le Boisselier, J Alexandre, V Lelong-Boulouard & D Debruyne. (2017) Focus on cannabinoids and synthetic cannabinoids. Clinical Pharmacology & Therapeutics 101:2, pages 220-229.
Crossref
Crossref
David Hakimian, Orr Tomer, Nurith Hiller, Samuel N. Heyman & Sarah Israel. (2017) Fatal Mesenteric Ischemia Induced by Synthetic Cannabinoids: A Case Report and Literature Review. Case Reports in Emergency Medicine 2017, pages 1-5.
Crossref
Crossref
Martin O. Olsson, Agneta Öjehagen, Louise Brådvik, Robert Kronstrand & Anders Håkansson. (2017) High Rates of Tramadol Use among Treatment-Seeking Adolescents in Malmö, Sweden: A Study of Hair Analysis of Nonmedical Prescription Opioid Use. Journal of Addiction 2017, pages 1-9.
Crossref
Crossref
Amandine Scocard, Amine Benyamina, Sarah Coscas & Laurent Karila. (2017) Cannabinoïdes de synthèse : une nouvelle matrice des addictions. La Presse Médicale 46:1, pages 11-22.
Crossref
Crossref
Lirit N. Franks, Benjamin M. Ford & Paul L. Prather. (2016) Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity. Frontiers in Pharmacology 7.
Crossref
Crossref
Hélène Peyrière, Céline Eiden, Michel Mallaret & Caroline Victorri-Vigneau. (2016) Medical complications of psychoactive substances with abuse risks: Detection and assessment by the network of French addictovigilance centres. Therapies 71:6, pages 563-573.
Crossref
Crossref
Martin H. Bluth & Matthew R. Pincus. (2016) Narcotic Analgesics and Common Drugs of Abuse. Clinics in Laboratory Medicine 36:4, pages 603-634.
Crossref
Crossref
Austin Adair, Spencer C. Greene, Christopher S. Greeley, Ryan D. Coleman & Lara S. Shekerdemian. (2016) Synthetic Cannabinoid Exposure. Clinical Pediatrics 55:11, pages 1075-1077.
Crossref
Crossref
George Loeffler, Eileen Delaney & Michael Hann. (2016) International trends in spice use: Prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids. Brain Research Bulletin 126, pages 8-28.
Crossref
Crossref
Maiko Kusano, Mayumi Yamanaka, Kei Zaitsu, Hiroshi Nakayama, Jun’ichi Nakajima, Takako Moriyasu, Hitoshi Tsuchihashi & Akira Ishii. (2016) Regioisomeric differentiation of the alkyl-substituted synthetic cannabinoids JWH-122 and JWH-210 by GC-EI-MS/MS. Forensic Toxicology 34:2, pages 304-315.
Crossref
Crossref
Gianluigi Tanda. (2016) Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg. Psychopharmacology 233:10, pages 1845-1866.
Crossref
Crossref
Elisabeth Leere Øiestad, Åse Marit Leere Øiestad, Astrid Gjelstad & Ritva Karinen. (2016) Oral fluid drug analysis in the age of new psychoactive substances. Bioanalysis 8:7, pages 691-710.
Crossref
Crossref
Ashraf Mozayani. (2016) How Present Synthetic Cannabinoids Can Help Predict Symptoms in the Future. MOJ Toxicology 2:1.
Crossref
Crossref
Martine M. Solages. (2015)
Synthetic Cannabinoids
∗
. Child and Adolescent Psychopharmacology News 20:5, pages 1-3,8,10.
Crossref
Crossref